ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 168 filers reported holding ASCENDIS PHARMA A/S in Q1 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,879,159 | +19.3% | 21,055 | +43.3% | 0.01% | 0.0% |
| Q1 2023 | $1,575,491 | -15.8% | 14,694 | -4.1% | 0.01% | -16.7% |
| Q4 2022 | $1,871,887 | +14.2% | 15,327 | -3.4% | 0.01% | +20.0% |
| Q3 2022 | $1,639,000 | -10.0% | 15,868 | -19.0% | 0.01% | 0.0% |
| Q2 2022 | $1,821,000 | -43.6% | 19,588 | -28.7% | 0.01% | -28.6% |
| Q1 2022 | $3,226,000 | -0.3% | 27,488 | +14.3% | 0.01% | +16.7% |
| Q4 2021 | $3,236,000 | -15.6% | 24,053 | 0.0% | 0.01% | -25.0% |
| Q3 2021 | $3,834,000 | +21.2% | 24,053 | 0.0% | 0.01% | +14.3% |
| Q2 2021 | $3,164,000 | +18.9% | 24,053 | +16.5% | 0.01% | +16.7% |
| Q1 2021 | $2,661,000 | -34.0% | 20,646 | -14.6% | 0.01% | -33.3% |
| Q4 2020 | $4,030,000 | +42.7% | 24,166 | +32.1% | 0.01% | +28.6% |
| Q3 2020 | $2,824,000 | – | 18,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 11,225,357 | $1,001,863,112 | 18.92% |
| Q Global Advisors, LLC | 195,000 | $17,404 | 12.55% |
| Sofinnova Investments, Inc. | 754,032 | $67,297,356 | 4.41% |
| Avoro Capital Advisors LLC | 3,580,555 | $319,564,534 | 4.34% |
| Finepoint Capital LP | 139,772 | $12,474,651 | 4.32% |
| Spyglass Capital Management LLC | 657,853 | $58,713,380 | 4.24% |
| Saturn V Capital Management LP | 78,442 | $7,000,948 | 3.88% |
| DAFNA Capital Management LLC | 135,212 | $12,067,671 | 3.30% |
| ARS Investment Partners, LLC | 289,860 | $25,870,005 | 3.02% |
| Ghost Tree Capital, LLC | 100,000 | $8,925,000 | 2.95% |